DUSA PHARMACEUTICALS, INC.
NASDAQ : DUSA

DUSA PHARMACEUTICALS, INC.

July 29, 2005 08:00 ET

DUSA Pharmaceuticals, Inc. To Host Second Quarter 2005 Corporate Highlights And Financial Results Conference Call

WILMINGTON, MASSACHUSETTS--(CCNMatthews - July 29, 2005) - DUSA Pharmaceuticals, Inc. (NASDAQ NMS:DUSA) announces that its second quarter corporate highlights and financial results press release will be issued on Wednesday, August 3, 2005 at 7:00 a.m. to be followed by a conference call at 8:45 a.m.



Wednesday, August 3, 8:45 a.m. Eastern
If calling from the US or Canada use the following toll-free number:
800.936.4602
Password - DUSA

For International callers use
507.726.3418
Password - DUSA

A recorded replay of the call will be available by 12:00 pm
North American callers 800.334.2128
International callers 580.431.2986


The call will be accessible on our web site after 1:00 p.m. www.dusapharma.com.

DUSA Pharmaceuticals, Inc. is a biopharmaceutical company engaged primarily in the development of Levulan® Photodynamic Therapy (PDT) and Photodetection (PD) for multiple medical conditions, with its primary focus in dermatology. PDT and PD utilize light-activated compounds to induce a therapeutic or detection effect. DUSA maintains offices in Wilmington, MA, Valhalla, NY and Toronto, Ontario.

Contact Information

  • DUSA Pharmaceuticals, Inc.
    Shari Lovell
    Director, Shareholder Services
    416.363.5059
    416.363.6602 (FAX)
    www.dusapharma.com